Stereotactic ablative radiation therapy (SABR) is used in non-oncologic indications, recently even for cardiac arrhythmias. Thus, aim of this analysis is to review preclinical, early clinical evidences and future direction of the latter new treatment approach.A collection of available data regarding ...
Image-guided stereotactic ablative radiotherapy (SABR; also called stereotactic body radiotherapy) delivers focused, ablative radiation doses to a target while minimizing the dose to surrounding critical normal structures. It has produced local control rates in excess of 90% for patients with early stag...
Stereotactic ablative radiotherapy (SABR) has emerged standardtreatment peripherallylocated medically inoperable stage non-smallcell lung cancer (NSCLC) (1-5). SABR,local control primarytumors greaterthan 90% tumorsup regionallymph node recurrence within low(5% 10%).Distant metastasis remains dominant...
Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment of ...
Stereotactic ablative radiotherapy (SABR) is a standard-of-care for medically-inoperable-early-stage non-small cell lung cancer (NSCLC). One third of patients progress and chemotherapy is rarely used in this population. We questioned if addition of the immune-checkpoint-inhibitor (ICI) atezolizumab...
FIGURE 1. Stereotactic ablative radiotherapy (SABR) for oligometastatic lung cancer. A 58-year-old woman treated with SABR for 2 lung metastases from colorectal caner (26 Gy in a single fraction each, prescribed to the 80% isodose line, over 2 days). TABLE 1. Clinical Trials of Stereotactic...
Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020;38:2830–8. Article PubMed PubMed Central Google Scholar Francolini G, Gaetano Allegra A, Detti B, Di Cataldo V, Cai...
摘要: 目前肺癌在全球已成为对生命威胁最大的肿瘤.立体定向放射外科(stereotactic ablative radiotherapy,SABR),又称为体部立体定向放疗(stereotactic body radiotherapy,SBRT),已成为不可手术临床Ⅰ期非小细胞肺癌(non small cell lung cancer,NSCLC)的标准治疗.但是,... 查看全部>>...
0笔记 摘要原文 To update the 2012 UK stereotacticablative radiotherapy (SABR) Consortium survey and assess the development of SABR services across the UK over the past 6 years. Use the results to share practice and continue to drive forward technique development, aid standardization and by highlight...
Stereotactic Ablative Radiotherapy Versus Surgery in Early Lung Cancer: A Meta-Analysis of Propensity Score StudiesPURPOSE: As no completed randomized trials of surgery versus stereotactic ablative radiation therapy (SABR) in patients with early-stage non-small cell lung cancer are available, numerous ...